Psoriasin (S100A7) expression and invasive breast cancer

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 2057-2066

  Al Haddad, Sahar ^a   Zhang, Zi ^a   Leygue, Etienne ^a   Snell, Linda ^a   Huang, Aihua ^a   Niu, Yulian ^a   Hiller Hitchcock, Tamara ^a   Hole, Kate ^a   Murphy, Leigh C ^a   Watson, Peter H ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN S 100; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER INFILTRATION; CANCER INVASION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR GROWTH;

EID: 0032794404     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65524-1     Document Type: Article

References (44)

1. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC Watson PH: Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 1996, 56:4606-4609
2. Schafer BW, Heizmann CW: The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996, 21:134-140
3. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R: Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycyt dine treatment. Proc Natl Acad Sci USA 1992, 89:2504-2508
4. Lloyd BH, Platt-Higgins A, Rudland PS, Barraclough R: Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene 1998, 17:465-473
5. Sherbet GV, Lakshmi MS: S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res 1998, 18: 2415-2421
6. Grigorian M, Ambartsumian N, Lykkesfeldt AE, Bastholm L, Elling F, Georgiev G, Lukanidin E: Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer 1996, 67:831-841
7. Ford HL, Salim MM, Chakravarty R, Aluiddin V, Zain SB: Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene 1995, 11:2067-2075
8. Bastholm L, Elling F, Georgiev G, Lukanidin EKM, Tarabykina S, Bronstein I, Maitland N, Lomonosov M, Hansen K, Georgiev G, Lukanidin E: Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem 1998, 273:9852-9856
9. Ford HL, Zain SB: Interaction of metastasis associated Mts1 protein with nonmuscle myosin Oncogene 1995, 10:1597-1605
10. Keirsebilck A, Bonne S, Bruyneel E, Vermassen P, Lukanidin E, Mareel M, Van Roy F: E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. Cancer Res 1998, 58:4587-4591
11. Borglum AD, Flint T, Madsen P, Celis JE, Kruse TA Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21. Hum Genet 1995, 96:592-596
12. Hoffmann HJ, Olsen E, Etzerodt M, Madsen P, Thogersen HC, Kruse T, Celis JE: Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin J Invest Dermatol 1994, 103:370-375
13. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et al : Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991, 97:701-712
14. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honore B, Celis JE, Thestrup Pedersen K: Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996, 107:5-10.
15. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Wolf H, Orntoft TF: Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996, 155:2105-2112
16. Watson PH, Leygue ER, Murphy LC: Psoriasin (S100A7). Int J Biochem Cell Biol 1998, 30:567-571
17. Hiller T, Snell L, Watson PH: Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections. Biotechniques 1996, 21:38-40
18. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW: Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992, 20:479-489
19. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410
20. Leygue ER, Watson PH, Murphy LC: Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 1996, 88:284-290
21. Schagger H, von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987, 166:368-379
22. Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, Watson PH, Murphy LC: Expression of lumican in human breast carcinoma. Cancer Res 1998, 58:1348-1352
23. Ercolani L, Florence B, Denaro M, Alexander M: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988, 263:15335-15341
24. Ilg EC, Schafer BW, Heizmann CW: Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer 1996, 68: 325-332
25. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE: Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 1997, 57:4111-4117
26. Kohn EC, Liotta LA: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995, 55:1856-1862
27. Munn KE, Walker RA, Varley JM: Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 1995, 10:1653-1657
28. Wicki R, Franz C, Scholl FA, Heizmann CW, Schafer BW: Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 1997, 22: 243-254
29. 2+-binding protein family Genes Dev 1989, 3:1086-1093
30. Barraclough R, Rudland PS: The S-100-related calcium-binding protein, p9Ka, and metastasis in rodent and human mammary cells. Eur J Cancer 1994, 30A:1570-1576
31. Albertazzi E, Cajone F, Leone BE, Naguib RN, Lakshmi MS, Sherbet GV: Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression. DNA Cell Biol 1998, 17:335-342
32. Grigorian MS, Tulchinsky EM, Zain S, Ebralidze AK, Kramerov DA, Kriajevska MV, Georgiev GP, Lukanidin EM: The mts1 gene and control of tumor metastasis. Gene 1993, 135:229-238
33. Moog-Lutz C, Bouillet P, Regnier CH, Tomasetto C, Mattei MG, Chenard MP, Anglard P, Rio MC, Basset P: Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int J Cancer 1995, 63:297-303
34. Yarden RI, Lauber AH, El Ashry D, Chrysogelos SA: Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinology 1996, 137:2739-2747
35. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S, Livingston DM: Location of BRCA1 in human breast and ovarian cancer cells (technical comments). Science 1996, 272:123-124.
36. Chen Y, Chen P-L, Riley DJ, Lee W-H, Alfred DC, Osborne CK: Location of BRCA1 in human breast and ovarian cancer cells (technical comments). Science 1996, 272:125-126
37. Ishida-Yamamoto A, Takahashi H, Presland RB, Dale BA, Iizuka H: Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab Invest 1998, 78:1245-1253
38. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nature Genet 1999, 21:236-240
39. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK, Lee WH: Aberrant subcellular localization of BRCA1 in breast cancer. Science 1995, 270:789-791
40. Sheng H, Shao J, Williams CS, Pereira MA, Taketo MM, Oshima M, Reynolds AB, Washington MK, DuBois RN, Beauchamp RD: Nuclear translocation of beta-catenin in hereditary and carcinogen-induced intestinal adenomas. Carcinogenesis 1998, 19:543-549
41. Hessian PA, Edgeworth J, Hogg N: MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993, 53:197-204
42. Albertazzi E, Cajone F, Lakshmi MS, Sherbet GV: Heat shock modulates the expression of the metastasis associated gene MTS1 and proliferation of murine and human cancer cells. DNA Cell Biol 1998, 17:1-7
43. Yang Q, O'Hanlon D, Heizmann CW, Marks A: Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma. Exp Cell Res 1999, 246:501-509
44. Mandinova A, Atar D, Schafer BW, Spiess M, Aebi U, Heizmann CW: Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J Cell Sci 1998, 111:2043-2054